Effects of hydrodynamic forces on coronary production of prostacyclin and purines.
Prostacyclin and purine efflux rates from the isolated rabbit heart in response to variations of flow rate or perfusion pressure were investigated. Increases in coronary flow by 25, 50, and 100% augmented the effluxes of 6-ketoprostaglandin F1 alpha (6-keto-PGF1 alpha) and purines equally, by up to four times. Increases in coronary pressure by 25, 50, and 100% augmented the outflow of 6-keto-PGF1 alpha by up to 20 times, whereas the outflow of purines increased no more than 6.5 times. Neither reduction of perfusate Ca2+ by 50% nor administration of quinacrine (1 microM) affected the basal efflux of 6-keto-PGF1 alpha or its response to an increase in coronary pressure. Both interventions did, however, reduce the pressure-induced purine efflux by approximately 50%. Pulsatile flow did not affect either the outflow of 6-keto-PGF1 alpha or that of purines, in comparison to steady flow at the same rate. The data demonstrate that an increase in coronary pressure activates a specific mechanism for prostacyclin production that appears independent of extracellular Ca2+ and of phospholipase activity.
Karwatowska-Prokopczuk
E
E
Department of Clinical Physiology, Gothenburg University, Sahlgrenska Hospital, Göteborg, Sweden.
Ciabattoni
G
G
Wennmalm
A
A
D015121:6-Ketoprostaglandin F1 alpha / Q000096:biosynthesis*; D000818:Animals; D001794:Blood Pressure; D002118:Calcium / Q000494:pharmacology; D003326:Coronary Circulation; D005260:Female; D006321:Heart / Q000187:drug effects; D007700:Kinetics; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D010477:Perfusion; D011687:Purines / Q000096:biosynthesis*; D011796:Quinacrine / Q000494:pharmacology; D011817:Rabbits
D011687:Purines; D015121:6-Ketoprostaglandin F1 alpha; D011796:Quinacrine; D002118:Calcium